Related Experiment Video

Updated: Sep 19, 2025

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.6K

The landscape for radioligand therapies in oncology

Jerrick To, Rachel Magid, Jon Cleland

    Nature Reviews. Drug Discovery
    |June 3, 2025
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
    09:08

    Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

    Published on: December 20, 2024

    1.5K
    Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
    08:45

    Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

    Published on: November 13, 2012

    13.8K

    Related Experiment Videos

    Last Updated: Sep 19, 2025

    Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
    09:06

    Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

    Published on: February 3, 2023

    1.6K
    Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
    09:08

    Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

    Published on: December 20, 2024

    1.5K
    Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
    08:45

    Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

    Published on: November 13, 2012

    13.8K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    7.8K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    Taking Care of the Caregivers: A Quality-of-Life Measure for the Parents of Children With Transfusion-Dependent Thalassemia.

    Pediatric blood & cancer·2025

    Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti: an open-label, randomised, non-inferiority trial.

    The lancet. HIV·2025

    Basicity-Controlled C-H Bond Activation by a Structurally Characterized Ni(III)-Hydroxo Complex.

    Journal of the American Chemical Society·2025

    Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers.

    The oncologist·2025

    Speed of innovation: How quickly are different therapeutic areas adopting paradigm-shifting drugs?

    Drug discovery today·2024

    Thymic stromal lymphopoietin induces IL-4/IL-13 from T cells to promote sebum secretion and adipose loss.

    The Journal of allergy and clinical immunology·2023

    Solute carrier membrane transporters: emerging targets in CNS disorders.

    Nature reviews. Drug discovery·2026

    Towards precision psychiatry: initial foundations and future directions.

    Nature reviews. Drug discovery·2026

    Targeting CDKs in the RNAPII transcription cycle.

    Nature reviews. Drug discovery·2026

    Artificial intelligence in drug discovery - what it is, where we stand and the path forward.

    Nature reviews. Drug discovery·2026

    Comparison of Esophageal Dose Parameters in Breast Cancer Radiotherapy With and Without Esophageal Contouring.

    Cureus·2026

    Staged Flexible Transurethral Lithotripsy After Robot-Assisted Partial Nephrectomy for Concomitant Renal Cell Carcinoma and Ipsilateral Nephrolithiasis: A Case Report.

    Cureus·2026

    Mechanistic insights into Strontium-90 superficial radiotherapy in keloids: senescence-associated changes and ECM remodeling across cell-matrix scales.

    Frontiers in pharmacology·2026

    Three-Dimensional Soft Tissue Reconstructive Planning in Orthoplastic Oncology: A Systematic Review.

    Cureus·2026

    [Role and Potential Mechanisms of Peroxisome Proliferator-Activated Receptor α in Ultraviolet B Radiation-Induced Skin Damage].

    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2026

    A clinical evaluation of HyperSight CBCT enhanced offline adaptive breast radiotherapy.

    Frontiers in oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us